Medications for Muscular Atrophy

11 results

Abigale (estradiol and norethindrone acetate)

(estradiol and norethindrone acetate)
Xiromed LLC
Usage: Abigale and Abigale Lo are indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as the prevention of postmenopausal osteoporosis, particularly in women at significant risk. Topical products and non-estrogen medications should be considered first for certain indications.
Bayer HealthCare Pharmaceuticals Inc.
Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.
Noven Therapeutics, LLC
Usage: CombiPatch is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause in women with a uterus, as well as for hypoestrogenism resulting from hypogonadism, castration, or primary ovarian failure.
Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Usage: Estradiol tablets are indicated for treating moderate to severe menopausal symptoms, vulvar and vaginal atrophy, hypoestrogenism, breast cancer (palliative), advanced androgen-dependent prostate cancer (palliative), and for preventing osteoporosis in women at significant risk when non-estrogen therapies are inappropriate.
Teva Pharmaceuticals USA, Inc.
Usage: Estradiol tablets are indicated for treating moderate to severe menopause symptoms, vulvar and vaginal atrophy, hypoestrogenism, and for palliation in breast cancer and prostate cancer. They may also be used for preventing osteoporosis in postmenopausal women at significant risk when non-estrogen options are unsuitable.
Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Usage: Estradiol Tablets USP are indicated for treating moderate to severe menopausal symptoms, hypoestrogenism from various causes, metastatic breast cancer (palliation), advanced androgen-dependent prostate cancer (palliation), and prevention of osteoporosis in at-risk postmenopausal women when non-estrogen options are unsuitable.
PD-Rx Pharmaceuticals Inc
Usage: Estradiol tablets are indicated for treating moderate to severe menopausal vasomotor symptoms, vulvar and vaginal atrophy, hypoestrogenism, palliation of certain breast and prostate cancers, and prevention of osteoporosis in at-risk postmenopausal women. Topical products may be preferred for vaginal atrophy.
DIRECT RX
Usage: Estradiol Tablets are indicated for treating moderate to severe menopausal vasomotor symptoms, vulvar and vaginal atrophy, hypoestrogenism, palliation in breast cancer and advanced prostate carcinoma, and prevention of osteoporosis in at-risk postmenopausal women when non-estrogen options are inappropriate.
Pfizer Laboratories Div Pfizer Inc
Usage: ESTRING is indicated for treating moderate to severe vulvar and vaginal atrophy symptoms resulting from menopause.
ASCEND Therapeutics US, LLC
Usage: The drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause. It is recommended to consider topical vaginal products for isolated vulvar and vaginal atrophy symptoms before prescribing this medication.